Targeting mutant p53 for efficient cancer therapy
By V. Bykov, S. Eriksson, Julie Bianchi, K. Wiman. Nature Reviews. Cancer, 2017
796 citations recorded by the source corpus.
Subfields: Biotechnology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/2af55c5d4575d384a15d053da30294fc42d8e254
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- The role of ubiquitination in tumorigenesis and targeted drug discovery (2020, background): “In addition, p53 also plays an important role in cell metabolism by inhibiting glycolysis and promoting oxidative phosphorylation in response to nutrient stimulation.(214,215) Under the stimulation of low carcinogenicity and genotoxicity, p53 is persistently expressed, but its protein level is often”
- Targeting p53 pathways: mechanisms, structures and advances in therapy (2023, background): “3,4 p53 protein functions primarily as a transcription factor, which regulates a wide variety of pathways, such as cell cycle arrest, DNA repair, cell apoptosis, autophagy, and metabolism, 1,5,6 and determines whether cells die under stress conditions.”